论文部分内容阅读
肝素作为抗凝药物在临床上应用已半个多世纪的历史。其抗凝,抗血栓形成,降低血液粘度,改善微循环等作用越来越被临床重视。我院自1992年2月至1994年10月应用小剂量肝素治疗慢性乙型病毒性肝炎74例,经同期比较观察疗效满意。现报告如下: 1、资料与方法 1.1、病例选择;随机选择我科住院的慢性乙型病毒性肝炎146例,分肝素组74例,对照组72例。临床诊断均符合90年上海第六次全国病毒性肝炎学术会议制定的诊断标准。 1.2、一般资料;肝素组74例,男46例,女28
Heparin as anticoagulant drugs in clinical application has more than half a century of history. Its anticoagulant, anti-thrombosis, lower blood viscosity, improve microcirculation and other effects of more and more clinical attention. Our hospital from February 1992 to October 1994 application of small doses of heparin in the treatment of 74 cases of chronic hepatitis B, compared with the same period to observe the satisfactory results. Now report as follows: 1, data and methods 1.1, case selection; random selection of hospitalized patients with chronic hepatitis B 146 cases, sub-heparin group 74 cases, control group 72 cases. Clinical diagnosis are in line with the 90th Shanghai Sixth National Conference on the development of viral hepatitis diagnostic criteria. 1.2, general information; heparin group of 74 cases, 46 males and 28 females